ArticleCancer2017

Prognostic factors and survival outcomes in patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era: Cohort study of 477 patients.

Preetesh Jain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.